GDUFA II Negotiations: Contract Manufacturers Gain Seat At Table
Executive Summary
Generic user fees could be segmented further by addition of new group.
You may also be interested in...
Excipients Group Seeks Seat At GDUFA Negotiating Table
IPEC-Americas requests an improved communications channel with the FDA and formal inclusion in talks to reauthorize the generic drug user fee program; agency says industry negotiators generally represent product manufacturers and API suppliers that are subject to user fees.
GDUFA III: Excipients Group Seeks Seat At Negotiating Table, But US FDA Skeptical
IPEC-Americas requests an improved communications channel with the FDA and formal inclusion in talks to reauthorize the generic drug user fee program; agency says industry negotiators generally represent product manufacturers and API suppliers that are subject to user fees.
Generic User Fee Renewal Talks Faced 'Buyer's Remorse' From GDUFA I
Industry dismay at slow pace of ANDA approvals and FDA communications in early years of first user fee agreement factored into GDUFA II negotiations.